OptimizeRx (OPRX) Set to Announce Earnings on Tuesday

OptimizeRx (NASDAQ:OPRX) will issue its quarterly earnings data after the market closes on Tuesday, May 14th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

OptimizeRx (NASDAQ:OPRX) last issued its earnings results on Tuesday, April 16th. The company reported $0.11 earnings per share (EPS) for the quarter. OptimizeRx had a negative return on equity of 7.72% and a negative net margin of 24.56%. The company had revenue of $28.37 million during the quarter. On average, analysts expect OptimizeRx to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

OptimizeRx Price Performance

NASDAQ OPRX opened at $10.62 on Tuesday. The business’s fifty day simple moving average is $12.02 and its 200-day simple moving average is $12.18. The company has a quick ratio of 3.04, a current ratio of 3.04 and a debt-to-equity ratio of 0.27. The firm has a market cap of $193.07 million, a PE ratio of -10.51 and a beta of 1.05. OptimizeRx has a 52 week low of $6.92 and a 52 week high of $16.65.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Stifel Nicolaus reaffirmed a “buy” rating and set a $13.00 target price on shares of OptimizeRx in a research note on Monday, April 1st. JMP Securities reiterated a “market outperform” rating and issued a $15.00 price objective on shares of OptimizeRx in a report on Tuesday, April 16th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $17.00 price objective on shares of OptimizeRx in a research report on Monday, April 1st. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, OptimizeRx presently has an average rating of “Moderate Buy” and a consensus target price of $15.86.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow.